Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19905)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lopez NE, Prendergast C, Lowy AM. Borderline resectable pancreatic cancer: Definitions and management. World J Gastroenterol 2014; 20(31): 10740-10751 [PMID: 25152577 DOI: 10.3748/wjg.v20.i31.10740] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10740.htm |
| Number | Citing Articles |
| 1 |
Jashodeep Datta, Charles M. Vollmer. Advances in Surgical Management of Pancreatic Diseases. Gastroenterology Clinics of North America 2016; 45(1): 129 doi: 10.1016/j.gtc.2015.10.002
|
| 2 |
Ziying Zhu, Saisong Xiao, Haojie Hao, Qian Hou, Xiaobing Fu. Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutations in the Occurrence and Treatment of Pancreatic Cancer. Current Topics in Medicinal Chemistry 2019; 19(23): 2176 doi: 10.2174/1568026619666190828160804
|
| 3 |
Suneetha Amara, Li V. Yang, Venkataswarup Tiriveedhi, Mahvish Muzaffar. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications. Cells 2022; 11(12): 1900 doi: 10.3390/cells11121900
|
| 4 |
Pedro Moutinho-Ribeiro, Julio Iglesias-Garcia, Rui Gaspar, Guilherme Macedo. Early pancreatic cancer — The role of endoscopic ultrasound with or without tissue acquisition in diagnosis and staging. Digestive and Liver Disease 2019; 51(1): 4 doi: 10.1016/j.dld.2018.09.027
|
| 5 |
Benedetto Ielpo, Riccardo Caruso, Hipolito Duran, Eduardo Diaz, Isabel Fabra, Luis Malavé, Valentina Ferri, Rafael Alvarez, Antonio Cubillo, Carlos Plaza, Sara Lazzaro, Denis Kalivaci, Yolanda Quijano, Emilio Vicente. A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma. Surgical Oncology 2017; 26(4): 402 doi: 10.1016/j.suronc.2017.08.003
|
| 6 |
Wilson Petrushnko, Justin S. Gundara, Philip R. De Reuver, Greg O'Grady, Jaswinder S. Samra, Anubhav Mittal. Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma. HPB 2016; 18(8): 652 doi: 10.1016/j.hpb.2016.05.004
|
| 7 |
Nada El Kayal, Simon Lennartz, Sandra Ekdawi, Jasmin Holz, Karin Slebocki, Stefan Haneder, Christian Wybranski, Ahmed Mohallel, Mohamed Eid, Holger Grüll, Thorsten Persigehl, Jan Borggrefe, David Maintz, Carola Heneweer. Value of spectral detector computed tomography for assessment of pancreatic lesions. European Journal of Radiology 2019; 118: 215 doi: 10.1016/j.ejrad.2019.07.016
|
| 8 |
Daniel Åkerberg, Daniel Ansari, Roland Andersson, Bobby Tingstedt. The Effects of Surgical Exploration on Survival of Unresectable Pancreatic Carcinoma: A Retrospective Case-Control Study. Journal of Biomedical Science and Engineering 2017; 10(01): 1 doi: 10.4236/jbise.2017.101001
|
| 9 |
Saad Saffo, Chengwei Peng, Ronald Salem, Tamar Taddei, Anil Nagar. Impact of Neoadjuvant Chemotherapy and Pretreatment Biliary Drainage for Pancreatic Head Ductal Adenocarcinoma. Digestive Diseases and Sciences 2022; 67(4): 1409 doi: 10.1007/s10620-021-06967-7
|
| 10 |
Molecular Processes Involved in Pancreatic Cancer and Therapeutics. Current Chemical Biology 2021; 15(1): 85 doi: 10.2174/2212796814999201008130819
|
| 11 |
Dhiresh K Maharjan, Roshan Ghimire, Yugal Limbu, Sujan Regmee, Rabin Pahari, Suman K Shrestha, Prabin Bikram Thapa. Strategies in the Management of Pancreatic Ductal Adenocarcinoma Involving Aberrant Right Hepatic Artery Arising From the Superior Mesenteric Artery. Cureus 2022; doi: 10.7759/cureus.30781
|
| 12 |
Shaina Templeton, Michael Moser, Chris Wall, John Shaw, Haji Chalchal, Yigan Luo, Adnan Zaidi, Shahid Ahmed. Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy. Journal of Gastrointestinal Cancer 2021; 52(2): 529 doi: 10.1007/s12029-020-00417-9
|
| 13 |
Han‐Xiang Zhan, Jian‐Wei Xu, Dong Wu, Zhi‐Yang Wu, Lei Wang, San‐Yuan Hu, Guang‐Yong Zhang. Neoadjuvant therapy in pancreatic cancer: a systematic review and meta‐analysis of prospective studies. Cancer Medicine 2017; 6(6): 1201 doi: 10.1002/cam4.1071
|
| 14 |
Michail Papoulas, Sawsan Abdul-Hamid, Praveen Peddu, Corina Cotoi, Nigel Heaton, Krishna Menon. Irreversible electroporation in borderline resectable pancreatic adenocarcinoma for margin accentuation. Journal of Surgical Case Reports 2018; 2018(6) doi: 10.1093/jscr/rjy127
|
| 15 |
Meng Lu, Chun‑Hui Yuan, Ling‑Fu Zhang, Lian‑Yuan Tao, Ying Peng, Li‑Mei Guo, Gang Li, Dian‑Rong Xiu. Pathological analysis of the superior mesenteric artery boundary in preoperative computed tomography of resectable pancreatic head adenocarcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10269
|
| 16 |
Susanna W. L. de Geus, Teviah E. Sachs. A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer. Annals of Surgical Oncology 2023; 30(6): 3427 doi: 10.1245/s10434-023-13281-1
|
| 17 |
Muhammad B. Darwish, Shankar Logarajah, Patrick J. McLaren, Annie L. Benzie, Jason Schmidt, Assad J. Saad, Mauricio Salicru, Terence Jackson, Shyam Vedantam, Jeffery Carenza, Clayton Sanders, Kei Nagatomo, Edward Cho, Houssam Osman, Dhiresh Rohan Jeyarajah. “Infiltrative” Versus “Mass-Forming” Pancreatic Cancer: A New Radiological Classification System for Pancreatic Head Ductal Carcinoma and Its Pathological Correlation. Journal of Pancreatic Cancer 2022; 8(1): 9 doi: 10.1089/pancan.2022.0003
|
| 18 |
Jing Li, Yunmei Li, Chong Chen, Jiayu Guo, Mengmeng Qiao, Jun Lyu. Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: A model-based period analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1049136
|
| 19 |
James F. Griffin, Christopher L. Wolfgang. Pancreatic Cancer. 2017; : 175 doi: 10.1007/978-3-662-47181-4_14
|
| 20 |
Joseph P. Doyle, Pranav H. Patel, Nikoletta Petrou, Joshua Shur, Matthew Orton, Sacheen Kumar, Ricky H. Bhogal. Radiomic applications in upper gastrointestinal cancer surgery. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02951-z
|
| 21 |
Longlan Zhou, Lin Zhang. Effect of postsurgical adjuvant chemotherapy timing on outcomes in patients with pancreatic cancer – a systematic review and meta-analysis. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2402175
|
| 22 |
D. A. Chichevatov, V. V. Kalentjev, A. E. Glukhov. Single vein resection in surgery for pancreatic ductal carcinoma as a criterion of resectability. Siberian journal of oncology 2022; 21(4): 25 doi: 10.21294/1814-4861-2022-21-4-25-31
|
| 23 |
|
| 24 |
James A. Brown, Mazen S. Zenati, Richard L. Simmons, Amr I. Al Abbas, Asmita Chopra, Katelyn Smith, Kenneth K.W. Lee, Melissa E. Hogg, Herbert J. Zeh, Alessandro Paniccia, Amer H. Zureikat. Long-Term Surgical Complications After Pancreatoduodenectomy: Incidence, Outcomes, and Risk Factors. Journal of Gastrointestinal Surgery 2020; 24(7): 1581 doi: 10.1007/s11605-020-04641-3
|
| 25 |
Nobuyuki Nishizawa, Hiroki Harada, Yusuke Kumamoto, Takashi Kaizu, Hiroshi Katoh, Hiroshi Tajima, Hideki Ushiku, Keigo Yokoi, Kazuharu Igarashi, Yoshiki Fujiyama, Kosuke Okuwaki, Tomohisa Iwai, Masahiko Watanabe, Keishi Yamashita. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. Cancer Science 2019; 110(9): 2846 doi: 10.1111/cas.14134
|
| 26 |
David Ebuka Arthur, Adamu Uzairu. Molecular docking studies on the interaction of NCI anticancer analogues with human Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. Journal of King Saud University - Science 2019; 31(4): 1151 doi: 10.1016/j.jksus.2019.01.011
|
| 27 |
Wesley Field, Jack W. Rostas, Robert C.G. Martin. Quality of life assessment for patients undergoing irreversible electroporation (IRE) for treatment of locally advanced pancreatic cancer (LAPC). The American Journal of Surgery 2019; 218(3): 571 doi: 10.1016/j.amjsurg.2019.03.020
|
| 28 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 29 |
Eric Pion, Julia Karnosky, Sofie Boscheck, Benedikt J. Wagner, Katharina M. Schmidt, Stefan M. Brunner, Hans J. Schlitt, Thiha Aung, Christina Hackl, Silke Haerteis. 3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model. Cancers 2022; 14(15): 3733 doi: 10.3390/cancers14153733
|
| 30 |
Ya Wang, Emilia Timotin, Waqaas Zia, Tom Farrell, Harold Reiter, Bonnie Chan, Raimond Wong. Pain Palliation Using Hypofractionated Radiotherapy for Unresectable Pancreatic Cancer. Journal of Medical Imaging and Radiation Sciences 2018; 49(3): 293 doi: 10.1016/j.jmir.2018.04.033
|
| 31 |
Ryan D. Nipp, Angela C. Tramontano, Chung Yin Kong, Chin Hur. Patterns and predictors of end‐of‐life care in older patients with pancreatic cancer. Cancer Medicine 2018; 7(12): 6401 doi: 10.1002/cam4.1861
|
| 32 |
Charles H. C. Pilgrim, Anna Maciejewska, Nadia Ayres, Sam Ellis, Mark Goodwin, John R. Zalcberg, Andrew Haydon. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot. ANZ Journal of Surgery 2022; 92(10): 2565 doi: 10.1111/ans.17999
|
| 33 |
Adam Kowalewski, Łukasz Szylberg, Michał Saganek, Wojciech Napiontek, Paulina Antosik, Dariusz Grzanka. Emerging strategies in BRCA-positive pancreatic cancer. Journal of Cancer Research and Clinical Oncology 2018; 144(8): 1503 doi: 10.1007/s00432-018-2666-9
|
| 34 |
Helen S. Earley, Vikram Tewatia, Kevin C. Conlon. Textbook of Pancreatic Cancer. 2021; : 817 doi: 10.1007/978-3-030-53786-9_52
|
| 35 |
Aleksandra Tarasiuk, Grzegorz Mirocha, Jakub Fichna. Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview. Current Treatment Options in Oncology 2023; 24(12): 1852 doi: 10.1007/s11864-023-01146-4
|
| 36 |
Anthony D. Nehlsen, Karyn A. Goodman. Controversies in radiotherapy for pancreas cancer. Journal of Surgical Oncology 2021; 123(6): 1460 doi: 10.1002/jso.26313
|
| 37 |
Sushmita Pathy, Antony George Francis, Soumyajit Roy. Comments on - Neoadjuvant Chemo-radiation with IMRT in Resectable and Borderline Resectable Pancreatic Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(13): 5585 doi: 10.7314/APJCP.2015.16.13.5585
|
| 38 |
Ashish Verma. Surgery for Pancreatic and Periampullary Cancer. 2018; : 45 doi: 10.1007/978-981-10-7464-6_4
|
| 39 |
Deesje Doppenberg, E. van Veldhuisen, O. R. Busch, G. van Tienhoven, J. W. Wilmink, Marc. G. Besselink. Textbook of Pancreatic Cancer. 2021; : 729 doi: 10.1007/978-3-030-53786-9_47
|
| 40 |
Pranav Murthy, Mazen S. Zenati, Amr I. Al Abbas, Caroline J. Rieser, Nathan Bahary, Michael T. Lotze, Herbert J. Zeh, Amer H. Zureikat, Brian A. Boone. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer. Annals of Surgical Oncology 2020; 27(3): 898 doi: 10.1245/s10434-019-08094-0
|
| 41 |
Pierluigi di Sebastiano, Tommaso Grottola, F. Francesco di Mola. Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy. Updates in Surgery 2016; 68(3): 235 doi: 10.1007/s13304-016-0392-x
|
| 42 |
Robert Memba, Donal B. O’Connor, Kevin C. Conlon. Minimally Invasive Surgery of the Pancreas. Updates in Surgery 2018; : 75 doi: 10.1007/978-88-470-3958-2_8
|
| 43 |
Savannah R. Smith, Mohammad Raheel Jajja, Juan M. Sarmiento, Kenneth Cardona. Anatomic, Physiologic, and Therapeutic Principles of Surgical Diseases. 2023; : 327 doi: 10.1007/978-3-031-25596-0_19
|
| 44 |
Kazuyuki Gyoten, Shugo Mizuno, Motonori Nagata, Toru Ogura, Masanobu Usui, Shuji Isaji. Significance of Simultaneous Splenic Artery Resection in Left‐Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein Resection. World Journal of Surgery 2017; 41(8): 2111 doi: 10.1007/s00268-017-3916-8
|
| 45 |
Alfredo Carrato, Davide Melisi, Gerald Prager, Christoph B Westphalen, Anabel Ferreras, Nathalie D’Esquermes, Julien Taieb, Teresa M Mercadé. Chart Review of Diagnostic Methods, Baseline Characteristics and Symptoms for European Patients with Pancreatic Cancer. Future Oncology 2021; 17(15): 1843 doi: 10.2217/fon-2020-0749
|
| 46 |
Ijin Joo, Jeong Min Lee, Eun Sun Lee, Su Joa Ahn, Dong Ho Lee, Sun-Whe Kim, Ji Kon Ryu, Do-Youn Oh, Kyubo Kim, Kyoung-Bun Lee, Jin-Young Jang. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy. American Journal of Roentgenology 2018; 210(5): 1059 doi: 10.2214/AJR.17.18310
|
| 47 |
H. Duan, L. Baratto, R. Laudicella, F. Stracuzzi, S. Baldari, A. Iagaru. Molecular imaging of pancreatic neoplasms. Clinical and Translational Imaging 2021; 9(2): 141 doi: 10.1007/s40336-020-00408-7
|
| 48 |
Fotini Poyia, Christiana M. Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences 2024; 25(17): 9555 doi: 10.3390/ijms25179555
|
| 49 |
Mohamedraed Elshami, Fasih A. Ahmed, Hanna Kakish, Jonathan J. Hue, Richard S. Hoehn, Luke D. Rothermel, David Bajor, Amr Mohamed, Jennifer E. Selfridge, John B. Ammori, Jeffrey M. Hardacre, Jordan M. Winter, Lee M. Ocuin. Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancers. HPB 2023; 25(2): 239 doi: 10.1016/j.hpb.2022.11.003
|
| 50 |
Alberto Meyer, Bárbara J Carvalho, Kayo AA Medeiros, Leonardo Z Pipek, Fernanda S Nascimento, Milena O Suzuki, João VT Munhoz, Leandro R Iuamoto, Luiz A Carneiro-D'Alburquerque, Wellington Andraus. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report. World Journal of Clinical Cases 2021; 9(14): 3418-3423 doi: 10.12998/wjcc.v9.i14.3418
|
| 51 |
Amanda S. Huynh, Allison S. Cohen, Michael Doligalski, Todd J. Casagni, Valerie E. Moberg, Xuan Huang, Jennifer Morse, Dominique Abrahams, Mark C. Lloyd, Barbara A. Centeno, Margaret K. Baldwin, Mark L. McLaughlin, Josef Vagner, David L. Morse. Intraoperative Guidance of Pancreatic Cancer Resection Using a Toll-like Receptor 2–Targeted Fluorescence Molecular Imaging Agent. Cancer Research Communications 2024; 4(11): 2877 doi: 10.1158/2767-9764.CRC-24-0244
|
| 52 |
|
| 53 |
Martijn R. Meijerink, Anders Nilsson, Govindarajan Narayanan, Robert Martin. Irreversible Electroporation in Clinical Practice. 2018; : 167 doi: 10.1007/978-3-319-55113-5_11
|
| 54 |
Daniel A. Smith, Bhanusupriya Somarouthu, Nikhil H. Ramaiya. An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know. Abdominal Radiology 2019; 44(6): 2182 doi: 10.1007/s00261-019-01954-z
|
| 55 |
Steve Robatel, Mirjam Schenk. Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment. Cancers 2022; 14(4): 985 doi: 10.3390/cancers14040985
|
| 56 |
Viviana Cortiana, Harshitha Vallabhaneni, Jade Gambill, Soumiya Nadar, Kennedy Itodo, Chandler H. Park, Yan Leyfman. Advancing Pancreatic Cancer Surgical Treatments and Proposal of New Approaches. Cancers 2024; 16(16): 2848 doi: 10.3390/cancers16162848
|
| 57 |
Sue M. Evans, Kris Ivanova, Danca Cossio, Charles H. C. Pilgrim, Daniel Croagh, John Zalcberg, Dalisay Giffard, Nikkitia Golobic, Bruno Di Muzio, Catriona McLean C, Kate McLean, Gregory C. Miller, Susanna Nicosia, Nick O’Rourke, Sumit Parikh, Richard Standish, Luc te Marvelde, Caroline Watts. Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia. PLOS ONE 2024; 19(1): e0294443 doi: 10.1371/journal.pone.0294443
|
| 58 |
灏辰 仲. A Case of Pancreatic Cancer Treated with DP Car after Combined Chemotherapy with HIFU. Advances in Clinical Medicine 2021; 11(06): 2533 doi: 10.12677/ACM.2021.116364
|
| 59 |
Diego A.S. Toesca, Amanda J. Koong, George A. Poultsides, Brendan C. Visser, Sigurdis Haraldsdottir, Albert C. Koong, Daniel T. Chang. Management of Borderline Resectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 2018; 100(5): 1155 doi: 10.1016/j.ijrobp.2017.12.287
|
| 60 |
G. G. Karmazanovsky. Differential diagnosis and analysis of pancreatic cancer resectability using CT and MRI. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(3): 22 doi: 10.16931/1995-5464.2019322-35
|
| 61 |
Seok Jeong Yang, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee. Preoperative defining system for pancreatic head cancer considering surgical resection. World Journal of Gastroenterology 2016; 22(26): 6076-6082 doi: 10.3748/wjg.v22.i26.6076
|
| 62 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|
| 63 |
Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas, Ryan M. Thomas, Steven J Hughes, Ibrahim Nassour, Kathryn Hitchcock, Karen Russell, Omar Kayaleh, Anita Turk, Robert Zlotecki, David L DeRemer, Thomas J George. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma. Future Oncology 2023; 19(27): 1843 doi: 10.2217/fon-2023-0256
|
| 64 |
Thomas Seufferlein, Pascal Hammel, Jean Robert Delpero, Teresa Macarulla, Per Pfeiffer, Gerald W. Prager, Michele Reni, Massimo Falconi, Philip A. Philip, Eric Van Cutsem. Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence. Cancer Treatment Reviews 2019; 77: 1 doi: 10.1016/j.ctrv.2019.05.007
|
| 65 |
Saber Amin, Michael Baine, Jane Meza, Chi Lin. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07016-8
|
| 66 |
Dean Ehrlich, Nimah Ather, Harman Rahal, Timothy R. Donahue, O. Joe Hines, Stephen Kim, Alireza Sedarat, V. Raman Muthusamy, Rabindra Watson. The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. Journal of Gastrointestinal Surgery 2020; 24(12): 2807 doi: 10.1007/s11605-019-04415-6
|
| 67 |
Vanita Noronha, Vijay Patil, Pankaj Chaturvedi, Vijayalakshmi Mathrudev, Nandini Menon, Atanu Bhattacharjee, Ajay Singh, Zoya Peelay, Shatabdi Chakraborty, Monica Jadhav, Mitali Alone, Priyanka Bhagyavant, Manali Kolkur, Sujay Srinivas, Sudeep Das, Somnath Roy, Tanmoy Mandal, Hollis Dsouza, Saswata Saha, Rahul Rai, Anne Srikanth, Darshit Shah, Arif Khan, Hemanth Muthuluri, Amit Kumar, Amit Agarwal, Anu Rajpurohit, Vasu Babu Goli, Anbarasan Sekar, Anoop Mantri, Aditya Pavan Kumar Kanteti, Swaratika Majumdar, Satvik Khaddar, Ramnath Shenoy, Prahlad Elamarthi, Narmadha Rathnasamy, Lakhan Kashyap, George Abraham, Naveen Booma, Vijay Simha, Devendra Chaukar, Prathamesh Pai, Sudhir Nair, Sarbani Laskar, Kavita Nawale, Priyanka Naidu, Sushmita Salian, Priyanka Shelar, Ravinarayan Raulo, Sachin Babanrao Dhumal, Kumar Prabhash. Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer 2024; 200: 113560 doi: 10.1016/j.ejca.2024.113560
|
| 68 |
Christelle Bouchart, Julie Navez, Jean Closset, Alain Hendlisz, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem. Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920936093
|
| 69 |
Ke Sun, Wei Li, Jun Han, Hong Wu. Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5966-9
|
| 70 |
Lorenzo Maroni, Matteo Ravaioli, Antonio Daniele Pinna. Why is pancreatic adenocarcinoma not screened for earlier?. Expert Review of Anticancer Therapy 2016; 16(10): 1003 doi: 10.1080/14737140.2016.1224972
|
| 71 |
Azadeh Tabari, Shin Mei Chan, Omar Mustafa Fathy Omar, Shams I. Iqbal, Michael S. Gee, Dania Daye. Role of Machine Learning in Precision Oncology: Applications in Gastrointestinal Cancers. Cancers 2022; 15(1): 63 doi: 10.3390/cancers15010063
|
| 72 |
Nicholas McDonald, Syed Ahmad, Kyuran Ann Choe. Knowing Your Boundaries: A Review of the Definitions and Imaging Features of Borderline Resectable Pancreatic Carcinoma. Seminars in Roentgenology 2016; 51(2): 82 doi: 10.1053/j.ro.2016.02.001
|
| 73 |
Nitin Sudhakar Shetty, Ujjwal Agarwal, Amit Choudhari, Anurag Gupta, Nandakumar PG, Manish Bhandare, Kunal Gala, Daksh Chandra, Anant Ramaswamy, Vikas Ostwal, Shailesh V. Shrikhande, Suyash S. Kulkarni. Imaging Recommendations for Diagnosis, Staging, and Management of Pancreatic Cancer. Indian Journal of Medical and Paediatric Oncology 2023; 44(01): 077 doi: 10.1055/s-0042-1759521
|
| 74 |
Giorgio Romano, Antonino Agrusa, Massimo Galia, Giuseppe Di Buono, Daniela Chianetta, Vincenzo Sorce, Leonardo Gulotta, Giuseppe Brancatelli, Gaspare Gulotta. Whipple’s pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center. International Journal of Surgery 2015; 21: S68 doi: 10.1016/j.ijsu.2015.06.062
|
| 75 |
Tanveer Singh, Adarsh Chaudhary. Improving Survival of Pancreatic Cancer. What Have We Learnt?. Indian Journal of Surgery 2015; 77(5): 436 doi: 10.1007/s12262-015-1368-7
|
| 76 |
Kezhong Tang, Wenjie Lu, Wenjie Qin, Yulian Wu. Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages. Pancreatology 2016; 16(1): 28 doi: 10.1016/j.pan.2015.11.007
|
| 77 |
I. Montejo Gañán, L.F. Ángel Ríos, L. Sarría Octavio de Toledo, M.E. Martínez Mombila, L.H. Ros Mendoza. Estadificación mediante tomografía computarizada del carcinoma de páncreas. Radiología 2018; 60(1): 10 doi: 10.1016/j.rx.2017.08.004
|
| 78 |
J.A. Hwang, K.M. Jang, S.H. Kim, T.W. Kang, K.D. Song, D.I. Cha, S. Ahn. Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour–vascular interface in correlation with surgical and pathological outcomes. Clinical Radiology 2018; 73(3): 321.e1 doi: 10.1016/j.crad.2017.11.001
|
| 79 |
Donald L. Ly, Seng Thipphavong, Boraiah Sreeharsha. Pictorial review of vascular involvement and complex vascular reconstructions in borderline to minimally advanced pancreatic malignancies. Abdominal Radiology 2017; 42(11): 2675 doi: 10.1007/s00261-017-1172-x
|
| 80 |
Charikleia Triantopoulou, Kleo Papaparaskeva, Christos Agalianos, Christos Dervenis. Innovations in macroscopic evaluation of pancreatic specimens and radiologic correlation. European Journal of Radiology Open 2016; 3: 49 doi: 10.1016/j.ejro.2016.02.001
|
| 81 |
J.W. Gilbert, B. Wolpin, T. Clancy, J. Wang, H. Mamon, A.B. Shinagare, J. Jagannathan, M. Rosenthal. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Annals of Oncology 2017; 28(9): 2067 doi: 10.1093/annonc/mdx180
|
| 82 |
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
|
| 83 |
Hryhoriy Lapshyn, Peter Bronsert, Louisa Bolm, Martin Werner, Ulrich T. Hopt, Frank Makowiec, Uwe A. Wittel, Tobias Keck, Ulrich F. Wellner, Dirk Bausch. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer. Langenbeck's Archives of Surgery 2016; 401(1): 63 doi: 10.1007/s00423-015-1363-2
|
| 84 |
S. V. Tarasenko, A. A. Natalsky, O. D. Peskov, S. N. Sokolova, T. S. Rakhmaev, I. V. Bakonina, A. Yu. Bogomolov, D. A. Glotov. Comparison of access to the superior mesenteric arteryduring the execution of the pancreatoduodenal resectionin patients with borderline-resectable cancer of the pancreatic head. Experimental and Clinical Gastroenterology 2023; (10): 97 doi: 10.31146/1682-8658-ecg-206-10-97-102
|
| 85 |
Aleksandra Adamska, Alice Domenichini, Marco Falasca. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. International Journal of Molecular Sciences 2017; 18(7): 1338 doi: 10.3390/ijms18071338
|
| 86 |
Biqi Zhang, Grace C. Lee, Motaz Qadan, Zhi Ven Fong, Mari Mino-Kenudson, Vikram Desphande, Giuseppe Malleo, Laura Maggino, Giovanni Marchegiani, Roberto Salvia, Aldo Scarpa, Claudio Luchini, Lucia De Gregorio, Cristina R. Ferrone, Andrew L. Warshaw, Keith D. Lillemoe, Claudio Bassi, Carlos Fernández-del Castillo. Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma. Annals of Surgery 2021; 274(2): e134 doi: 10.1097/SLA.0000000000003503
|
| 87 |
Teddy Sutardji Nagaria, Hua Wang, Deyali Chatterjee, Huamin Wang. Pathology of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications. Archives of Pathology & Laboratory Medicine 2020; 144(7): 838 doi: 10.5858/arpa.2019-0477-RA
|
| 88 |
Ammar A. Javed, Michael J. Wright, Ayat Siddique, Alex B. Blair, Ding Ding, Richard A. Burkhart, Martin Makary, John L. Cameron, Amol Narang, Joseph Herman, Lei Zheng, Daniel Laheru, Matthew J. Weiss, Christopher Wolfgang, Jin He. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy. Journal of Gastrointestinal Surgery 2019; 23(1): 112 doi: 10.1007/s11605-018-3966-8
|
| 89 |
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
|
| 90 |
Heying Duan, Lucia Baratto, Andrei Iagaru. The Role of PET/CT in the Imaging of Pancreatic Neoplasms. Seminars in Ultrasound, CT and MRI 2019; 40(6): 500 doi: 10.1053/j.sult.2019.04.006
|
| 91 |
|
| 92 |
Hussein H. Khachfe, Joseph R. Habib, Ibrahim Nassour, Salem Al Harthi, Faek R. Jamali. Borderline Resectable and Locally Advanced Pancreatic Cancers. Pancreas 2021; 50(9): 1243 doi: 10.1097/MPA.0000000000001924
|
| 93 |
Naveen Kumar, Anuraag Jena, Vishal Sharma, Siddharth Shukla, Jimil Shah. Outcome of metal vs plastic stents for biliary obstruction in patients with pancreatic carcinoma undergoing neoadjuvant chemoradiotherapy: A systematic review and meta‐analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2023; 30(4): 419 doi: 10.1002/jhbp.1240
|
| 94 |
U. A. Wittel, D. Lubgan, M. Ghadimi, O. Belyaev, W. Uhl, W. O. Bechstein, R. Grützmann, W. M. Hohenberger, A. Schmid, L. Jacobasch, R. S. Croner, A. Reinacher-Schick, U. T. Hopt, A. Pirkl, H. Oettle, R. Fietkau, H. Golcher. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6148-5
|
| 95 |
Sini Vehviläinen, Antti Kuuliala, Marianne Udd, Anna Nurmi, Katriina Peltola, Caj Haglund, Leena Kylänpää, Hanna Seppänen. Cholangitis and Interruptions of Neoadjuvant Chemotherapy Associate with Reduced Overall and Progression-Free Survival in Pancreatic Cancer. Annals of Surgical Oncology 2024; 31(4): 2621 doi: 10.1245/s10434-023-14793-6
|
| 96 |
M. Itchins, J. Arena, C.B. Nahm, J. Rabindran, S. Kim, E. Gibbs, S. Bergamin, T.C. Chua, A.J. Gill, R. Maher, C. Diakos, M. Wong, A. Mittal, G. Hruby, A. Kneebone, N. Pavlakis, J. Samra, S. Clarke. Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre. European Journal of Surgical Oncology 2017; 43(9): 1711 doi: 10.1016/j.ejso.2017.06.012
|
| 97 |
I. Montejo Gañán, L.F. Ángel Ríos, L. Sarría Octavio de Toledo, M.E. Martínez Mombila, L.H. Ros Mendoza. Staging pancreatic carcinoma by computed tomography. Radiología (English Edition) 2018; 60(1): 10 doi: 10.1016/j.rxeng.2017.08.003
|
| 98 |
Julien Taieb, Thomas Seufferlein, Michele Reni, Daniel H. Palmer, John A. Bridgewater, Antonio Cubillo, Gerald W. Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla. Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11377-1
|
| 99 |
Annick D. Van den Abbeele, Angela A. Giardino, Christopher G. Sakellis, Harris L. Cohen, Ashkan A. Malayeri, Pamela DiPiro, Donald N. Di Salvo, Fiona M. Fennessy, Stephanie H. Howard, Heather A. Jacene, Katherine M. Krajewski, Atul B. Shinagare, Sree Harsha Tirumani. . 2019; doi: 10.54057/cpi.ac2019
|
| 100 |
Mišo Gostimir, Sean Bennett, Terence Moyana, Harman Sekhon, Guillaume Martel. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2821-0
|
| 101 |
Violette Fossaert, Antonio Mimmo, Rami Rhaiem, Linda J. Rached, Mathilde Brasseur, Mathias Brugel, Francesca Pegoraro, Stephane Sanchez, Olivier Bouché, Reza Kianmanesh, Tullio Piardi. Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.980659
|
| 102 |
Hyung-Jun Im, Suthet Oo, Woohyun Jung, Jin-Young Jang, Sun-Whe Kim, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, E. Edmund Kim, Dong Soo Lee. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Medicine 2016; 95(19): e3686 doi: 10.1097/MD.0000000000003686
|
| 103 |
JUN GONG, RICHARD TULI, ARVIND SHINDE, ANDREW E. HENDIFAR. Meta-analyses of treatment standards for pancreatic cancer. Molecular and Clinical Oncology 2016; 4(3): 315 doi: 10.3892/mco.2015.716
|
| 104 |
Roland Andersson, Caj Haglund, Hanna Seppänen, Daniel Ansari. Pancreatic cancer – the past, the present, and the future. Scandinavian Journal of Gastroenterology 2022; 57(10): 1169 doi: 10.1080/00365521.2022.2067786
|
| 105 |
Lei Zhang, Zhui-Yang Zhang, Jian-Ming Ni, Bin Li, Fang-Ming Chen, Chun-Juan Jiang, Chun-Hong Hu. Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery. Journal of Computer Assisted Tomography 2017; 41(3): 394 doi: 10.1097/RCT.0000000000000530
|
| 106 |
Martin Sillesen, Carsten Palnæs Hansen, Emilie Even Dencker, Stefan Kobbelgaard Burgdorf, Paul Suno Krohn, Mogens Tornby Stender, Claus Wilki Fristrup, Jan Henrik Storkholm. Long-Term Outcomes of Venous Resections in Pancreatic Ductal Adenocarcinoma Patients. Annals of Surgery Open 2022; 3(4): e219 doi: 10.1097/AS9.0000000000000219
|
| 107 |
Evelyn Waugh, Juan Glinka, Daniel Breadner, Rachel Liu, Ephraim Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro. Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2): 229 doi: 10.14701/ahbps.23-107
|
| 108 |
E.A. Burmeister, M. Waterhouse, S.J. Jordan, D.L. O'Connell, N.D. Merrett, D. Goldstein, D. Wyld, V. Beesley, H. Gooden, M. Janda, R.E. Neale. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study. Pancreatology 2016; 16(5): 873 doi: 10.1016/j.pan.2016.06.010
|
| 109 |
Amanda Puleo, Midhun Malla, Brian A. Boone. Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. Pancreas 2022; 51(9): 1083 doi: 10.1097/MPA.0000000000002147
|
| 110 |
Tatsuma Sakaguchi, Sohei Satoi, Tomohisa Yamamoto, So Yamaki, Mitsugu Sekimoto. The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma. Surgery Today 2020; 50(4): 335 doi: 10.1007/s00595-020-01963-2
|
| 111 |
Debasmita Mukherjee, Srija Chakraborty, Lena Bercz, Liliana D’Alesio, Jessica Wedig, Molly A. Torok, Timothy Pfau, Hannah Lathrop, Shrina Jasani, Abigail Guenther, Jake McGue, Daniel Adu-Ampratwum, James R. Fuchs, Timothy L. Frankel, Maciej Pietrzak, Stacey Culp, Anne M. Strohecker, Aleksander Skardal, Thomas A. Mace. Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. iScience 2023; 26(8): 107408 doi: 10.1016/j.isci.2023.107408
|
| 112 |
|
| 113 |
Simon Gray, Nicola de Liguori Carino, Ganesh Radhakrishna, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara. Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinoma. European Journal of Surgical Oncology 2022; 48(6): 1198 doi: 10.1016/j.ejso.2022.02.014
|
| 114 |
Igor E. Khatkov, Roman E. Izrailov, Arthur A. Khisamov, Pavel S. Tyutyunnik, Abraham Fingerhut. Superior mesenteric–portal vein resection during laparoscopic pancreatoduodenectomy. Surgical Endoscopy 2017; 31(3): 1488 doi: 10.1007/s00464-016-5115-3
|
| 115 |
Min Kyu Sung, Ki Byung Song, Sarang Hong, Yejong Park, Bong Jun Kwak, Eunsung Jun, Woohyung Lee, Jae Hoon Lee, Dae Wook Hwang, Song Cheol Kim. Laparoscopic versus open pancreaticoduodenectomy with major vein resection for pancreatic head cancer. Journal of Hepato-Biliary-Pancreatic Sciences 2023; 30(7): 970 doi: 10.1002/jhbp.1317
|
| 116 |
Walid L. Shaib, Layal Sayegh, Chao Zhang, Astrid Belalcazar, Andrew Ip, Olatunji B. Alese, Mehmet Akce, Christina Wu, Yuesheng Qu, Shishir K. Maithel, David Kooby, Kenneth Cardona, Juan M. Sarmeinto, Bassel F. El-Rayes. Induction Therapy in Localized Pancreatic Cancer. Pancreas 2019; 48(7): 913 doi: 10.1097/MPA.0000000000001353
|
| 117 |
Ko Tomishima, Shigeto Ishii, Toshio Fujisawa, Muneo Ikemura, Hiroto Ota, Daishi Kabemura, Mako Ushio, Taito Fukuma, Sho Takahashi, Wataru Yamagata, Yusuke Takasaki, Akinori Suzuki, Koichi Ito, Hiroaki Saito, Akihito Nagahara, Hiroyuki Isayama. Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer. Cancers 2021; 13(16): 4224 doi: 10.3390/cancers13164224
|
| 118 |
Gaurav Sharma, Edward E. Whang, Daniel T. Ruan, Hiromichi Ito. Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis. Annals of Surgical Oncology 2015; 22(S3): 1229 doi: 10.1245/s10434-015-4711-0
|
| 119 |
B. Ielpo, H. Duran, E. Diaz, I. Fabra, R. Caruso, V. Ferri, L. Malavé, M. Hidalgo, R. Alvarez, C. Plaza, Y. Quijano, E. Vicente. Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma. European Journal of Surgical Oncology (EJSO) 2016; 42(9): 1394 doi: 10.1016/j.ejso.2016.01.006
|
| 120 |
Marco de Scordilli, Anna Michelotti, Diego Zara, Lorenza Palmero, Martina Alberti, Claudia Noto, Fabiana Totaro, Luisa Foltran, Michela Guardascione, Donatella Iacono, Elena Ongaro, Gianpiero Fasola, Fabio Puglisi. Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives. Critical Reviews in Oncology/Hematology 2023; 186: 104013 doi: 10.1016/j.critrevonc.2023.104013
|
| 121 |
Lin Li, Jessica Kasza, Ariadna Recasens, Liane Ioannou, Elysia Greenhill, Neil Merrett, David Cavallucci, Samantha Ellis, Helen Madgwick, Hyun Soo Ko, Lorraine Chantrill, Benjamin Loveday, Mehrdad Nikfarjam, Daniel Croagh, Jessica Yang, Andrew Dwyer, John Zalcberg, Charles Pilgrim. SCANPatient: study protocol for a multi-centre, batched, stepped wedge, comparative effectiveness, randomised clinical trial of synoptic reporting of computerised tomography (CT) scans assessing cancers of the pancreas. Trials 2024; 25(1) doi: 10.1186/s13063-024-08196-5
|
| 122 |
Katsuhisa Ohgi, Yusuke Yamamoto, Teiichi Sugiura, Yukiyasu Okamura, Takaaki Ito, Ryo Ashida, Takeshi Aramaki, Katsuhiko Uesaka. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series. Annals of Surgical Oncology 2017; 24(9): 2752 doi: 10.1245/s10434-017-5972-6
|
| 123 |
Faustino Mollinedo, Consuelo Gajate. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer. Cancers 2021; 13(16): 4173 doi: 10.3390/cancers13164173
|
| 124 |
Asha Kandathil, Rathan Subramaniam. Quarter-Century PET/Computed Tomography Transformation of Oncology. PET Clinics 2024; 19(2): 163 doi: 10.1016/j.cpet.2023.12.003
|